Aurélie Swalduz
2PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul
|Jun 09, 2022
Lorlatinib in Frontline Therapy for ALK+ Advanced Non-Small-Cell Lung Cancer: Still a Matter of Debate?Maurice Pérol, Aurélie Swalduz
Pageof 1
Frequent Collaborators
1 joint publications
Maurice Pérol
1 joint publications
Jessica J Lin
1 joint publications
Joshua C Horan
1 joint publications
Anupong Tangpeerachaikul
1 joint publications
Augusto Valdivia
1 joint publications
Melissa L Johnson
1 joint publications
Benjamin Besse
1 joint publications
D Ross Camidge
1 joint publications
Toshio Fujino
1 joint publications
Satoshi Yoda
